ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. Low JS, Jerak J, Tortorici MA, McCallum M, et al. Science 2022 Jul 12:eabq2679. doi: 10.1126/science.abq2679.

Read + Share

Amedeo Smart

Independent Medical Education

Low JS, Jerak J, Tortorici MA, McCallum M, et al. ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. Science 2022 Jul 12:eabq2679. doi: 10.1126/science.abq2679.
PMID: 35857703